{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:39Z","timestamp":1793327439208,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["25X010506036"],"award-info":[{"award-number":["25X010506036"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172084"],"award-info":[{"award-number":["82172084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571603"],"award-info":[{"award-number":["32571603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["25ZR1402237"],"award-info":[{"award-number":["25ZR1402237"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124593","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:53:36Z","timestamp":1788188016000},"page":"124593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Transforming adoptive macrophages into living immune amplifiers with intracellular nanobatteries to potentiate tumor immunotherapy"],"prefix":"10.1016","volume":"338","author":[{"given":"Haijing","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9024-509X","authenticated-orcid":false,"given":"Zejian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3709-072X","authenticated-orcid":false,"given":"Xiangdong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biomaterials.2026.124593_bib1","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2023.02.039","article-title":"Advances in cancer immunotherapies","volume":"186","author":"Dagher","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124593_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124593_bib3","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1021\/jacs.3c14005","article-title":"Nanomedicine remodels tumor microenvironment for solid tumor immunotherapy","volume":"146","author":"Guo","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124593_bib4","article-title":"Engineering biomaterials for next-generation cancer immunotherapy: from cell manufacturing to in vivo modulation","volume":"2","author":"Liu","year":"2026","journal-title":"Cell Biomater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124593_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124593_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124593_bib7","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal. Transduct. Tar."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124593_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124593_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124593_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202501954","article-title":"Inhibiting chemotherapy immune tolerance and reversing tumor microenvironment by macrophage-targeted nanohybrid systems for enhancing tumor chemo-immunotherapy","volume":"35","author":"Qin","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124593_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202009116","article-title":"A nano \"Immune-Guide\" recruiting lymphocytes and modulating the ratio of macrophages from different origins to enhance cancer immunotherapy","volume":"31","author":"Sun","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124593_bib12","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/acsnano.3c10037","article-title":"Tumor-microenvironment-activatable nanoparticle mediating immunogene therapy and M2 macrophage-targeted inhibitor for synergistic cancer immunotherapy","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124593_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124593_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41568-024-00699-2","article-title":"Exploiting temporal aspects of cancer immunotherapy","volume":"24","author":"Zemek","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124593_bib15","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1158\/2159-8290.CD-21-1683","article-title":"Next-generation CAR T-cell therapies","volume":"12","author":"Young","year":"2022","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124593_bib16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41551-023-01048-8","article-title":"Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR","volume":"7","author":"Zhang","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124593_bib17","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1007\/s00262-023-03490-8","article-title":"Chimeric antigen receptor macrophages activated through TLR4 or IFN-\u03b3 receptors suppress breast cancer growth by targeting VEGFR2","volume":"72","author":"Duan","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124593_bib18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124593_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124593_bib20","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124593_bib21","article-title":"Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","volume":"16","author":"Pierini","year":"2025","journal-title":"Nat. Commun."},{"issue":"656","key":"10.1016\/j.biomaterials.2026.124593_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn1128","article-title":"Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy","volume":"14","author":"Chen","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124593_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s40820-020-00531-0","article-title":"Nanoparticle-loaded polarized-macrophages for enhanced tumor targeting and cell-chemotherapy","volume":"13","author":"Hou","year":"2021","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.biomaterials.2026.124593_bib24","article-title":"An endosymbiotic system based on ATP-expressing bacteria and macrophages for cancer immunotherapy","volume":"2","author":"Li","year":"2026","journal-title":"Cell Biomater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124593_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-025-00950-1","article-title":"An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma","volume":"6","author":"Jing","year":"2025","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124593_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41578-024-00766-y","article-title":"Delivering living medicines with biomaterials","volume":"10","author":"Harimoto","year":"2025","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2026.124593_bib27","article-title":"The TLR7\/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer","volume":"10","author":"Michaelis","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124593_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2026.124593_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.09.042","article-title":"Drug-drug conjugates self-assembled nanomedicines triggered photo-\/immuno- therapy for synergistic cancer treatments","volume":"363","author":"Qu","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124593_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biomaterials.2018.01.044","article-title":"Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy","volume":"161","author":"Xue","year":"2018","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124593_bib31","article-title":"Stimuli-responsive crosslinked nanomedicine for cancer treatment","volume":"2","author":"Xue","year":"2022","journal-title":"Explorations"},{"issue":"5545","key":"10.1016\/j.biomaterials.2026.124593_bib32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.1065500","article-title":"Defective antigen processing in GILT-free mice","volume":"294","author":"Maric","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124593_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1073\/pnas.97.2.745","article-title":"Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT)","volume":"97","author":"Arunachalam","year":"2000","journal-title":"P. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124593_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-022-01296-w","article-title":"A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion","volume":"18","author":"Jin","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124593_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115246","article-title":"Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation","volume":"205","author":"Kusiak","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124593_bib36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.biomaterials.2026.124593_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03224-w","article-title":"Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246","volume":"9","author":"Cooks","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124593_bib38","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"issue":"38","key":"10.1016\/j.biomaterials.2026.124593_bib39","article-title":"The role of extracellular vesicles in the treatment of prostate cancer","volume":"20","author":"Hu","year":"2024","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124593_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/1878-0261.70007","article-title":"The roles and applications of extracellular vesicles in cancer","volume":"19","author":"Th\u00e9ry","year":"2025","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124593_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13894-9","article-title":"Tissue-infiltrating macrophages mediate an exosome-based metabolic reprogramming upon DNA damage","volume":"11","author":"Goulielmaki","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124593_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124593_bib43","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124593_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"de Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124593_bib45","doi-asserted-by":"crossref","first-page":"13267","DOI":"10.1007\/s12274-023-5912-7","article-title":"Charge-reversible crosslinked nanoparticle for pro-apoptotic peptide delivery and synergistic photodynamic cancer therapy","volume":"16","author":"Qu","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.biomaterials.2026.124593_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122745","article-title":"Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-\/immuno-therapy for cancer treatments","volume":"312","author":"Chen","year":"2025","journal-title":"Biomaterials"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:35:05Z","timestamp":1793324105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":46,"alternative-id":["S0142961226006174"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124593","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming adoptive macrophages into living immune amplifiers with intracellular nanobatteries to potentiate tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124593"}}